Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
Investigational New Drugs
|
December 14, 2019
Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells
Jie Hu, Enxin Wang, Lei Liu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 16, 2025
Interventional Radiological Management for Budd-Chiari Syndrome: A 10-Year Retrospective, Multicenter Survey on 997 Patients in China
Dongdong Xia, Bohan Luo, Chunqing Zhang, et al.
Liver Cancer
|
July 11, 2020
Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study
Zhexuan Wang, Enxin Wang, Wei Bai, et al.
Liver Cancer
|
August 18, 2022
Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study
Dongdong Xia, Wei Bai, Enxin Wang, et al.
Gut
|
November 12, 2018
Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study
Yong Lv, Luo Zuo, Xuan Zhu, et al.
European Radiology
|
April 6, 2022
Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization
Dongdong Xia, Qiuhe Wang, Wei Bai, et al.
Journal of Hepatology
|
January 21, 2019
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study
Qiuhe Wang, Dongdong Xia, Wei Bai, et al.
JHEP Reports : Innovation in Hepatology
|
January 6, 2025
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study<sup>☆</sup>
Dongdong Xia, Wei Bai, Qiuhe Wang, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
Investigational New Drugs
|
December 14, 2019
Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells
Jie Hu, Enxin Wang, Lei Liu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 16, 2025
Interventional Radiological Management for Budd-Chiari Syndrome: A 10-Year Retrospective, Multicenter Survey on 997 Patients in China
Dongdong Xia, Bohan Luo, Chunqing Zhang, et al.
Liver Cancer
|
July 11, 2020
Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study
Zhexuan Wang, Enxin Wang, Wei Bai, et al.
Liver Cancer
|
August 18, 2022
Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study
Dongdong Xia, Wei Bai, Enxin Wang, et al.
Gut
|
November 12, 2018
Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study
Yong Lv, Luo Zuo, Xuan Zhu, et al.
European Radiology
|
April 6, 2022
Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization
Dongdong Xia, Qiuhe Wang, Wei Bai, et al.
Journal of Hepatology
|
January 21, 2019
Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study
Qiuhe Wang, Dongdong Xia, Wei Bai, et al.
JHEP Reports : Innovation in Hepatology
|
January 6, 2025
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study<sup>☆</sup>
Dongdong Xia, Wei Bai, Qiuhe Wang, et al.
Page
of 7